Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)

Inclusion Criteria:

• Male or female, 12 years or older

• Initiating treatment with Dupixent for asthma according to the country-specificprescribing information

• Willing and able to comply with the required clinic visits, study procedures andassessments.

• Provided signed informed consent

Exclusion Criteria:

• Patients who have a contraindication to Dupixent according to the country-specificprescribing information

• Treatment with Dupixent within 6 months before the baseline visit. Note: forpatients who have been treated previously with DUPIXENT a washout period of 6 monthsis required before Visit 1.

• Any condition that, in the opinion of the Investigator, may interfere with patient'sability to participate in the study, such as short life expectancy, substance abuse,severe cognitive impairment, or other comorbidities that can predictably prevent thepatient from adequately completing the schedule of visits and assessments

• Patients currently participating in any interventional clinical trial which modifiespatient care.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.